Efficacy of lapatinib combined with capecitabine in patients with HER2-positive metastatic breast cancer in a real-world study

The aim of the present study was to determine the efficacy and safety of lapatinib-based treatment for patients with human epidermal growth factor receptor-2-positive (HER2(+)) metastatic breast cancer (MBC). The aim of the present real-world study was to investigate the medical records and follow-u...

Descripción completa

Detalles Bibliográficos
Autores principales: Gui, Xinyu, Li, Huiping, Yan, Ying, Zhang, Ruyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608029/
https://www.ncbi.nlm.nih.gov/pubmed/33154776
http://dx.doi.org/10.3892/ol.2020.12241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608029/
https://www.ncbi.nlm.nih.gov/pubmed/33154776
http://dx.doi.org/10.3892/ol.2020.12241

Ejemplares similares